Cargando…
Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population‐Based Registry
BACKGROUND: We sought to examine the mortality impact of appropriate implantable cardioverter defibrillator (ICD) therapy between patients who received ICD for primary versus secondary prevention purposes. METHODS AND RESULTS: From a prospective, population‐based registry, we identified 7020 patient...
Autores principales: | Almehmadi, Fahad, Porta‐Sánchez, Andreu, Ha, Andrew C. T., Fischer, Hadas D., Wang, Xuesong, Austin, Peter C., Lee, Douglas S., Nanthakumar, Kumaraswamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586459/ https://www.ncbi.nlm.nih.gov/pubmed/28862957 http://dx.doi.org/10.1161/JAHA.117.006220 |
Ejemplares similares
-
Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators
por: Lee, Douglas S., et al.
Publicado: (2015) -
The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot
por: Kawada, Satoshi, et al.
Publicado: (2021) -
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010) -
Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need
por: Tsuji, Yukiomi, et al.
Publicado: (2021) -
Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
por: Alla, Venkata M., et al.
Publicado: (2010)